These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 25053596

  • 21. Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.
    Li Y, Gong Y, Ning X, Peng D, Liu L, He S, Gong K, Zhang C, Li X, Zhou L.
    J Exp Clin Cancer Res; 2018 Nov 14; 37(1):276. PubMed ID: 30428910
    [Abstract] [Full Text] [Related]

  • 22. Proteomic identification of Reticulocalbin 1 as potential tumor marker in renal cell carcinoma.
    Giribaldi G, Barbero G, Mandili G, Daniele L, Khadjavi A, Notarpietro A, Ulliers D, Prato M, Minero VG, Battaglia A, Allasia M, Bosio A, Sapino A, Gontero P, Frea B, Fontana D, Destefanis P.
    J Proteomics; 2013 Oct 08; 91():385-92. PubMed ID: 23916412
    [Abstract] [Full Text] [Related]

  • 23. Down-regulation of PDCD4 expression is an independent predictor of poor prognosis in human renal cell carcinoma patients.
    Li X, Xin S, Yang D, Li X, He Z, Che X, Wang J, Chen F, Wang X, Song X.
    J Cancer Res Clin Oncol; 2012 Mar 08; 138(3):529-35. PubMed ID: 22203471
    [Abstract] [Full Text] [Related]

  • 24. Identification of FLOT2 as a novel target for microRNA-34a in melanoma.
    Liu R, Xie H, Luo C, Chen Z, Zhou X, Xia K, Chen X, Zhou M, Cao P, Cao K, Zhou J.
    J Cancer Res Clin Oncol; 2015 Jun 08; 141(6):993-1006. PubMed ID: 25403318
    [Abstract] [Full Text] [Related]

  • 25. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
    Tang J, Wang F, Cheng G, Si S, Sun X, Han J, Yu H, Zhang W, Lv Q, Wei JF, Yang H.
    J Exp Clin Cancer Res; 2018 Feb 27; 37(1):40. PubMed ID: 29482572
    [Abstract] [Full Text] [Related]

  • 26. CEP55 promotes epithelial-mesenchymal transition in renal cell carcinoma through PI3K/AKT/mTOR pathway.
    Chen H, Zhu D, Zheng Z, Cai Y, Chen Z, Xie W.
    Clin Transl Oncol; 2019 Jul 27; 21(7):939-949. PubMed ID: 30607788
    [Abstract] [Full Text] [Related]

  • 27. BUB1B Overexpression Is an Independent Prognostic Marker and Associated with CD44, p53, and PD-L1 in Renal Cell Carcinoma.
    Sekino Y, Han X, Kobayashi G, Babasaki T, Miyamoto S, Kobatake K, Kitano H, Ikeda K, Goto K, Inoue S, Hayashi T, Teishima J, Sakamoto N, Sentani K, Oue N, Yasui W, Matsubara A.
    Oncology; 2021 Jul 27; 99(4):240-250. PubMed ID: 33588420
    [Abstract] [Full Text] [Related]

  • 28. Evaluating the expression of CARMA3 as a prognostic tumor marker in renal cell carcinoma.
    Wu GL, Yuan JL, Huang XD, Rong JF, Zhang LX, Liu YP, Wang FL.
    Tumour Biol; 2013 Dec 27; 34(6):3431-5. PubMed ID: 23771851
    [Abstract] [Full Text] [Related]

  • 29. Analysis and Investigation of Bioinformatics and Epigenetics Reveal the Underlying Mechanisms by which FLOT2 Modulates the Progression of Diffuse Large B-cell Lymphoma.
    Zhang Y, Chen Y, Guo Q, Zhang Y, Liu A.
    Discov Med; 2024 Mar 27; 36(182):621-631. PubMed ID: 38531803
    [Abstract] [Full Text] [Related]

  • 30. Discoidin domain receptor 1 (DDR1), a promising biomarker, induces epithelial to mesenchymal transition in renal cancer cells.
    Song J, Chen X, Bai J, Liu Q, Li H, Xie J, Jing H, Zheng J.
    Tumour Biol; 2016 Aug 27; 37(8):11509-21. PubMed ID: 27020590
    [Abstract] [Full Text] [Related]

  • 31. miR-203 inhibition of renal cancer cell proliferation, migration and invasion by targeting of FGF2.
    Xu M, Gu M, Zhang K, Zhou J, Wang Z, Da J.
    Diagn Pathol; 2015 Apr 09; 10():24. PubMed ID: 25890121
    [Abstract] [Full Text] [Related]

  • 32. Expression and cytoplasmic localization of SAM68 is a significant and independent prognostic marker for renal cell carcinoma.
    Zhang Z, Li J, Zheng H, Yu C, Chen J, Liu Z, Li M, Zeng M, Zhou F, Song L.
    Cancer Epidemiol Biomarkers Prev; 2009 Oct 09; 18(10):2685-93. PubMed ID: 19755649
    [Abstract] [Full Text] [Related]

  • 33. Seminal plasma protein in renal cell carcinoma: expression of semenogelin I is a predictor for cancer progression and prognosis.
    Zhang S, Fang J, Zhang X, Qin C, Su S, Deng Y, Song Z, Zhang Y, Wang H, Yin C, Wang Z.
    Tumour Biol; 2014 Sep 09; 35(9):9095-100. PubMed ID: 25027395
    [Abstract] [Full Text] [Related]

  • 34. ZFX is a Strong Predictor of Poor Prognosis in Renal Cell Carcinoma.
    Li C, Li H, Zhang T, Li J, Ma F, Li M, Sui Z, Chang J.
    Med Sci Monit; 2015 Nov 05; 21():3380-5. PubMed ID: 26540164
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. MALAT1 accelerates the development and progression of renal cell carcinoma by decreasing the expression of miR-203 and promoting the expression of BIRC5.
    Zhang H, Li W, Gu W, Yan Y, Yao X, Zheng J.
    Cell Prolif; 2019 Sep 05; 52(5):e12640. PubMed ID: 31250518
    [Abstract] [Full Text] [Related]

  • 37. Cannabinoid receptor 2 as a novel target for promotion of renal cell carcinoma prognosis and progression.
    Wang J, Xu Y, Zhu L, Zou Y, Kong W, Dong B, Huang J, Chen Y, Xue W, Huang Y, Zhang J.
    J Cancer Res Clin Oncol; 2018 Jan 05; 144(1):39-52. PubMed ID: 28993942
    [Abstract] [Full Text] [Related]

  • 38. Activation of aryl hydrocarbon receptor promotes invasion of clear cell renal cell carcinoma and is associated with poor prognosis and cigarette smoke.
    Ishida M, Mikami S, Shinojima T, Kosaka T, Mizuno R, Kikuchi E, Miyajima A, Okada Y, Oya M.
    Int J Cancer; 2015 Jul 15; 137(2):299-310. PubMed ID: 25523818
    [Abstract] [Full Text] [Related]

  • 39. Protein expression of ZEB2 in renal cell carcinoma and its prognostic significance in patient survival.
    Fang Y, Wei J, Cao J, Zhao H, Liao B, Qiu S, Wang D, Luo J, Chen W.
    PLoS One; 2013 Jul 15; 8(5):e62558. PubMed ID: 23658743
    [Abstract] [Full Text] [Related]

  • 40. DCLK1 is a broadly dysregulated target against epithelial-mesenchymal transition, focal adhesion, and stemness in clear cell renal carcinoma.
    Weygant N, Qu D, May R, Tierney RM, Berry WL, Zhao L, Agarwal S, Chandrakesan P, Chinthalapally HR, Murphy NT, Li JD, Sureban SM, Schlosser MJ, Tomasek JJ, Houchen CW.
    Oncotarget; 2015 Feb 10; 6(4):2193-205. PubMed ID: 25605241
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.